Calprotectin May Be Biomarker of IPF Severity

Calprotectin May Be Biomarker of IPF Severity

284320

Calprotectin May Be Biomarker of IPF Severity

Calprotectin may serve as a blood biomarker for disease severity in patients with idiopathic pulmonary fibrosis (IPF), a new study indicates. Calprotectin blood levels are significantly higher in IPF patients and show a correlation with measures of lung function. The study, “Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts,” was published in the journal BMJ Open Respiratory Research. Pulmonary function tests are the standard…

You must be logged in to read/download the full post.